Now Available On-Demand! Free CE on CKD

The Whole Kidney and Caboodle: Incorporating Guideline-Based Recommendations to Identify and Manage Chronic Kidney Disease and Reduce Cardiovascular Risks

Most patients with chronic kidney disease (CKD) are unaware they have it. Guidelines have established well-known risk factors for CKD to help identify and screen patients, but many patients remain unscreened and untreated. Untreated CKD can lead to kidney disease progression, cardiovascular disease, morbidity, and mortality. As the most accessible healthcare professionals, pharmacists often interact with patients at risk for CKD when managing their chronic disease care or medications, uniquely positioning pharmacists to identify and screen patients at risk for CKD. Pharmacists can ensure patients are receiving guideline recommended care for CKD to improve outcomes and reduce cardiovascular risks. Pharmacists can also bridge care for patients with CKD and other cardiovascular-kidney-metabolic conditions through multidisciplinary collaboration and holistic care. This educational activity will present the cardiovascular risks of CKD and discuss approaches to identify and screen patients at risk for CKD. Patient cases will be utilized to illustrate the appropriate guideline-recommended care of CKD. Real-world examples of best practices in multidisciplinary care and patient education will be shared to equip and inspire pharmacists to bridge gaps across the cardiovascular-kidney-metabolic spectrum.

 We invite you to share this free educational activity with your colleagues.  

Featuring...

Katie Cardone

PharmD, BCACP, FNKF, FASN, FCCP
Activity Chair

 Professor and Chair, Department of Pharmacy Practice
Albany College of Pharmacy and Health Sciences
Albany, New York

Lavinia Salama 

PharmD, BCACP, BCGP, BC-ADM, CDCES

Clinical Assistant Professor - Long Island University, Arnold & Marie Schwartz College of Pharmacy and Health Sciences
Ambulatory Care Clinical Pharmacist - One Brooklyn Health, Pierre Toussaint Health Center
Brooklyn, New York

Target Audience

This activity was planned to meet the educational needs of pharmacists who practice in hospitals, health systems, community pharmacies, and ambulatory clinics who care for or are interested in the care of patients with chronic kidney disease.

Learning Objectives

• Apply guideline recommendations to identify and screen patients at risk of CKD using both uACR and eGFR to provide early identification, early access to treatment, and reduce the risk of kidney disease progression and adverse cardiovascular outcomes.
• Analyze guideline-based recommendations and clinical evidence for current and emerging therapies to reduce the risk for CKD progression as well as cardiovascular risks.  
• Prioritize opportunities within healthcare systems to bridge care and provide holistic, individualized care for people at risk for/with CKM syndrome.

Agenda

Welcome and Introductions
Katie Cardone
 

Identifying Patients and Providing Guideline-Based Screening for CKD 

Katie Cardone
 

Simplifying the Guidelines and Clinical Evidence to Provide Optimal Care for Patients with CKD  

Lavinia Salama
 

Interprofessional and Holistic Care in CKM Syndrome

All Faculty
 

Faculty Discussion, Questions and Answers

All Faculty

Accredited for CPE

ACPE #: 0204-0000-25-415-H01-P

CE Credit: 1.5 contact hours (0.15 CEUs)

Activity Type: Application-based

Activity Fee: No charge 

Available: February 19, 2026 - February 19, 2027

To receive CE credit, complete the steps below within 60 days of completing the activity.

1. View entire presentation and answer all polling questions.
2. Click "Complete Activity" on the last slide to complete the evaluation.
3. Verify credits were successfully transferred to CPE Monitor before the ACPE 60-day deadline by checking your NABP eProfile account.

After the 60-day deadline, ASHP will no longer be able to report credit(s).